SVA (Sinovac Biotech) Net Margin %: -40.96% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SVA Sinovac Biotech Ltd SVA
12 GF Score
Price $6.47
! 9 Warning Signs
View Full Analysis

What is Sinovac Biotech Net Margin %?

Sinovac Biotech SVA 12 Net Margin % is -40.96% as of Jun. 2026. GuruFocus rates SVA with a GF Score™ of 12/100. The stock has 9 warning signs investors should review.

Net margin is calculated as Net Income divided by its Revenue. Sinovac Biotech's Net Income for the six months ended in Jun. 2026 was $-60.2 Mil. Sinovac Biotech's Revenue for the six months ended in Jun. 2026 was $147.1 Mil. Therefore, Sinovac Biotech's net margin for the quarter that ended in Jun. 2026 was -40.96%.

The historical rank and industry rank for Sinovac Biotech's Net Margin % or its related term are showing as below:

SVA' s Net Margin % Range Over the Past 10 Years
Min: -24.39   Med: 12.14   Max: 43.7
Current: -24.39

SVA's Net Margin % is not ranked
in the Biotechnology industry.
Industry Median: -78.86 vs SVA: -24.39

Sinovac Biotech  (NAS:SVA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Sinovac Biotech Net Margin % Related Terms

Sinovac Biotech Net Margin % Historical Data

* Premium members only.

The historical data trend for Sinovac Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinovac Biotech Net Margin % Chart

Sinovac Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.70 7.63 -2.87 25.16 -15.46

Sinovac Biotech Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.92 -1.27 -16.63 -14.86 -40.96

SVA vs INBX, HLVX, KOD: Net Margin % Comparison

For the Biotechnology subindustry, Sinovac Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinovac Biotech Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinovac Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sinovac Biotech's Net Margin % falls into.


SVA
12GF Score
Sinovac Biotech Ltd SVA
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinovac Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sinovac Biotech's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-59.68/386.013
=-15.46 %

Sinovac Biotech's Net Margin for the quarter that ended in Jun. 2026 is calculated as

Net Margin=Net Income (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-60.237/147.079
=-40.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -40.96% mean?
Sinovac Biotech (SVA) has a Net Margin % of -40.96% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Sinovac Biotech and its competitors.
Is Sinovac Biotech's Net Margin % too high?
Sinovac Biotech's current Net Margin % is -40.96%. Overall, Sinovac Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Sinovac Biotech's Net Margin % compare to INBX and HLVX?
Sinovac Biotech's Net Margin % of -40.96% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sinovac Biotech and its competitors. Sinovac Biotech's current Net Margin % is -40.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinovac Biotech stock overvalued right now?
Sinovac Biotech (SVA) has a current Net Margin % of -40.96%. The current Net Margin % is -40.96%. Sinovac Biotech's overall GF Score™ is 12/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sinovac Biotech (SVA), the current Net Margin % is -40.96% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sinovac Biotech Business Description

Address No.39, Shangdi Xi Road, Haidan District, Beijing, CHN, 100085
Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.
12GF Score

Get the complete analysis for SVA

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.47
Price